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Marlène Mâıtre,1,2 Filippo Drago,4 Giovanni Marsicano,1,2,10,11,* and Edgar Soria-Gómez1,2,6,7,8,10,*
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https://doi.org/10.1016/j.celrep.2020.108046SUMMARYA complex array of inhibitory interneurons tightly controls hippocampal activity, but how such diversity spe-
cifically affects memory processes is not well understood. We find that a small subclass of type 1 cannabi-
noid receptor (CB1R)-expressing hippocampal interneurons determines episodic-like memory consolidation
by linking dopamine D1 receptor (D1R) signaling to GABAergic transmission. Mice lacking CB1Rs in D1-pos-
itive cells (D1-CB1-KO) display impairment in long-term, but not short-term, novel object recognition memory
(NOR). Re-expression of CB1Rs in hippocampal D1R-positive cells rescues this NORdeficit. Learning induces
an enhancement of in vivo hippocampal long-term potentiation (LTP), which is absent in mutant mice. CB1R-
mediatedNORand the associated LTP facilitation involve local control of GABAergic inhibition in aD1-depen-
dent manner.
This study reveals that hippocampal CB1R-/D1R-expressing interneurons control NORmemory, identifying a
mechanism linking the diversity of hippocampal interneurons to specific behavioral outcomes.INTRODUCTION
Formation of episodic memory is a multistep brain process that
requires activity of the medial temporal lobe (Squire et al., 2007).
The hippocampus in particular participates in long-term storage
of recently acquired events. Hippocampal circuits are regulated
by a large variety of local inhibitory interneurons that are
controlled by neuromodulatory systems ensuring their coordi-
nated function to shape behavioral responses (Klausberger
and Somogyi, 2008); the identities and functions of the interneu-
rons are under intense scrutiny (Harris et al., 2018; Pelkey et al.,
2017; Parra et al., 1998).
The endocannabinoid system is a brain-modulatory signaling
hub formed mainly by type 1 cannabinoid receptors (CB1Rs),
their endogenous ligands (endocannabinoids), and enzymes
for their synthesis and degradation. In the hippocampus,
CB1Rs are present in principal neurons and astroglial cells (Bus-
quets-Garcia et al., 2015; Oliveira da Cruz et al., 2016). However,
the largest expression of CB1Rs resides in GABAergic interneu-
rons (Marsicano and Kuner, 2008; Katona and Freund, 2012),This is an open access article under the CC BY-Nwhere they modulate local inhibition of hippocampal circuits.
Particularly, the largest amount of CB1Rs is expressed in chole-
cystokinin (CCK)-positive interneurons, which are characterized
by asynchronous neurotransmitter release (Harris et al., 2018;
Katona et al., 1999; Marsicano and Lutz, 1999).
Hippocampal CB1Rs control episodic-like memory processes
and synaptic plasticity (Robin et al., 2018; Hebert-Chatelain
et al., 2016; Puighermanal et al., 2009). However, the specific lo-
cationswhere these receptors participate in themechanisms un-
derlying hippocampus-dependent memory are only partially
known.
Activity-dependent long-term changes in hippocampal synap-
tic transmission are considered cellular correlates of memory
consolidation (Nicoll, 2017; Whitlock et al., 2006), which involves
local dopamine D1 receptor (D1R) signaling (Lisman et al., 2011;
Yamasaki and Takeuchi, 2017). Exposure to hippocampus-
dependent behavioral tasks induces changes in long-term
potentiation (LTP) of synaptic transmission that require activa-
tion of D1-like receptors (Frey et al., 1990; Granado et al.,




OPEN ACCESSnovel subpopulation of hippocampal CB1R/CCK-positive inter-
neurons containing D1R was recently described (Puighermanal
et al., 2017; Gangarossa et al., 2012). However, the potential in-
teractions between D1Rs and CB1Rs in regulating learning-
induced plasticity, activity of hippocampal circuits, and memory
processes remain unexplored.
Here we assessed the role of D1R/CB1R-positive cells in regu-
lation of episodic-like novel object recognition (NOR) memory.
We found that conditional deletion of the CB1R gene in hippo-
campal D1R-positive cells impairs long- but not short-term
NOR memory and learning-induced LTP enhancement involving
local control of GABAergic transmission. These intriguing results
suggest that CB1R signaling provides a functional link between
hippocampal dopaminergic and GABAergic control of synaptic
plasticity and memory consolidation.
RESULTS
CB1Rs in Hippocampal D1R-Positive Neurons Are
Necessary for Consolidation of NOR Memory
Mutant mice bearing a deletion of the CB1R gene in cells ex-
pressing D1R (D1-CB1-knockout [KO] mice; Monory et al.,
2007) displayed no phenotype in the short-term version (3 h
post-training) of a NOR task (Figures 1A and 1B; Puighermanal
et al., 2009; Busquets-Garcia et al., 2011; Robin et al., 2018).
Conversely, they showed strong impairment in long-term (24 h)
memory compared with their wild-type (WT) littermates (Fig-
ure 1C), with no changes in total exploration time (Figures
S1A–S1D).
The majority of CB1Rs in D1R-positive neurons have been
characterized previously in striatonigral circuits (Monory et al.,
2007). Considering the involvement of these circuits in NOR
memory (Darvas and Palmiter, 2009), we tested the role of stria-
tal CB1Rs.We infused an adeno-associated virus carrying a Cre-
dependent expression of CB1Rs (pAAV-CAG-DIO-CB1) into the
striatum of D1-CB1-KO mice to obtain re-expression (RS) of
CB1Rs in cells where Cre is present (hereafter called D1R-posi-
tive) in this brain region (striatum [STR]-CB1-RS mice; Figures
1D and 1E), as revealed by immunodetection of a myc-tagged
version of CB1Rs (CB1R-myc; STAR Methods; Figure 1E). This
re-expression was not sufficient to rescue the phenotype of
D1-CB1-KO mice in long-term NOR (Figures 1F, S1E, and S1F),
suggesting that CB1Rs in striatal D1R-positive cells do not partic-
ipate in this type of memory. Anatomical data indicate that a sub-
set of hippocampal neurons contain D1Rs (Gangarossa et al.,
2012), likely co-expressing CB1R protein (Puighermanal et al.,
2017). Thus, we re-express the CB1R gene in the hippocampus
of D1-CB1-KO mice to obtain hippocampus (HPC)-CB1-RS mice
(Figures 1D and 1G). This manipulation fully rescued the pheno-
type of themutant mice (Figure 1F, S1E, and S1F), indicating that
hippocampal CB1Rs expressed in D1R-positive cells are
required for NOR memory.
We recently reported that deletion of CB1Rs in hippocampal
glial acidic fibrillary protein (GFAP)-positive cells (i.e., mainly as-
trocytes, GFAP-CB1-KO mice) also impaired NOR memory
(Robin et al., 2018). Indeed, GFAP-CB1-KO mice were impaired
in NOR (Figures S1G–S1I; Robin et al., 2018), but, in contrast to
D1-CB1-KO mice, this phenotype extended to short-term NOR2 Cell Reports 32, 108046, August 18, 2020memory (Figures S1J–S1L). This difference suggests that
CB1Rs expressed in hippocampal astrocytes or D1R-positive
cells might control distinct phases of NOR memory
consolidation.
The primary function of CB1R activation in neurons is to
decrease neurotransmitter release (Castillo et al., 2012; Bus-
quets-Garcia et al., 2017). Accordingly, deletion of CB1Rs
from neurons often results in excessive neurotransmission.
Thus, we reasoned that inhibition of hippocampal D1R-positive
neurons during NOR consolidation should be able to rescue the
memory impairment of D1-CB1-KO mice. Viral vectors carrying
Cre-dependent expression of an inhibitory designer receptor
exclusively activated by designer drugs (DIO-hM4DGi, Gi-
DREADD; Robinson and Adelman, 2015) or control mCherry
protein were infused into the hippocampi of D1-CB1-KO mice
and WT littermates (Figure 1H). Post-training clozapine N-oxide
(CNO) injections did not affect the NOR performance of D1-
CB1-KO and WT mice injected with Gi-DREADD or mCherry,
indicating that the drug or its metabolites had no effect per
se (Gomez et al., 2017; Figures 1I, S1M, and S1N). Conversely,
post-acquisition CNO treatment fully rescued the NOR impair-
ment of D1-CB1-KO mice expressing Gi-DREADD (Figures 1I,
S1M, and S1N). This strongly suggests that excessive activity
of D1R-positive neurons during the consolidation process is
responsible for the memory impairment observed in D1-CB1-
KO mice.
CB1Rs in Hippocampal D1R-Positive Neurons Control
Learning-Induced Changes of LTP In Vivo
Cellular and molecular mechanisms underlying activity-depen-
dent changes in synaptic plasticity are proposed to underlie
long-termmemory (Aggleton andMorris, 2018). Previous studies
showed that conditional and global deletion of CB1Rs in neuronal
and glial cell populations induces deficits in learning and associ-
ated synaptic plasticity (Busquets-Garcia et al., 2017; Robin
et al., 2018). To address the role of CB1Rs in hippocampal
D1R-positive neurons in modulation of synaptic plasticity, we re-
corded in-vivo-evoked field excitatory postsynaptic potentials
(fEPSPs) in the hippocampal CA3-CA1 pathway of anesthetized
mice. High-frequency stimulation (HFS) induced similar long-
lasting LTP of synaptic fEPSPs in D1-CB1-KO andWT littermates
(Figures 2A and 2B), indicating that hippocampal D1R/CB1R-
positive neurons are dispensable for expression of LTP in naive
animals.
HPC-dependent memory-related processes such as LTP are
sensitive to pharmacological and genetic modulation of hippo-
campal D1Rs, particularly after learning (Li et al., 2003; Lemon
and Manahan-Vaughan, 2006; Takeuchi et al., 2016; Yamasaki
and Takeuchi, 2017). Thus, we hypothesized that CB1Rs in
D1R-positive neurons may modulate learning-dependent hippo-
campal synaptic plasticity. To explore whether acquisition of the
NOR task modulates in vivo LTP, we recorded fEPSPs from
C57Bl6/NRj mice after a NOR task (Figure 2C). HFS induced
stronger LTP in animals exposed to NOR acquisition than in con-
trol mice (Figures 2D and 2E), showing that the training modu-
lates hippocampal synaptic plasticity. Strikingly, D1-CB1-KO
mice lacked this learning-induced enhancement of LTP (Figures
2F and 2G). Thus, physiological activation of CB1Rs in
Figure 1. Hippocampal CB1Rs in D1R-Positive Cells Are Necessary for Late but Not Early Consolidation of NOR
(A) Schematic representation of the NOR memory task.
(B) Short-term (3 h) NOR memory performance of D1-CB1-WT mice (n = 10) and D1-CB1-KO littermates (n = 7).
(C) Long-term NOR (24 h) memory performance of D1-CB1-WT mice (n = 9) and D1-CB1-KO littermates (n = 8).
(D) Schematic representation of the experiment using viral re-expression of the CB1R gene in the striatum (STR) or the hippocampus (HPC) of D1-CB1-WT mice
and D1-CB1-KO littermates.
(E) Representative images of Cre-expressing D1-CB1-KOmice injected with CB1R-myc in the STR using the same procedure as described in (D) (STARMethods).
Scale bar, 2 mm.
(F) NORmemory performance of mice with re-expression of theCB1R gene in the STR or HPC. Control, n (D1-CB1-WT) = 17 and n (D1-CB1-KO) = 5; STR-CB1-RS,
n (D1-CB1-KO) = 6; HPC-CB1-RS, n (D1-CB1-KO) = 9.
(G) Immunofluorescence of cells expressing CB1R-myc in the HPC. Scale bar, 500 mm.
(H) Schematic representation of the experiment using viral expression of the Gi-DREADDs ormCherry in the HPC of D1-CB1-WTmice and D1-CB1-KO littermates.
Clozapine N-oxide (CNO; 2 mg/kg) injections take place after the training phase of the NOR task.
(I) NOR memory performance of D1-CB1-WT mice injected intra-hippocampally with hM4D(Gi) virus or mCherry (n VEH = 16, n CNO = 21), D1-CB1-KO mice
injected with mCherry (n VEH = 6, n CNO = 7), and D1-CB1-KO mice injected intra-hippocampally with hM4D(Gi) (n VEH = 11, n CNO = 14).
Data, mean ± SEM. *p < 0.05, ***p < 0.001, ****p < 0.0001. ns, not significant. See also Figure S1 and Table S1.
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OPEN ACCESShippocampal D1R-positive neurons is required for learning-
dependent facilitation of LTP.
CB1R in Hippocampal D1R-Positive Neurons Modulate
NORMemory Consolidation through aGABA-Dependent
Mechanism
D1Rs are expressed in different hippocampal cells, including
subsets of GABAergic and glutamatergic neurons (Gangarossa
et al., 2012). Considering that CB1R signaling decreases the ac-
tivity of hippocampal neurons (Busquets-Garcia et al., 2017;
Castillo et al., 2012), we asked whether excessive glutamatergic
or GABAergic neurotransmission might underlie the phenotype
of D1-CB1-KO mice. Thus, we injected non-amnesic doses
(Puighermanal et al., 2009) of the NMDA receptor blocker MK-
801, the AMPA/kainate receptor antagonist NBQX (Figure S2A),
or the GABAA receptor antagonist bicuculline into D1-CB1-KO
and WT littermates immediately after NOR training. MK-801
and NBQX did not alter memory performance in WT mice, nor
did it rescue the amnesic phenotype of D1-CB1-KO littermates
(Figures 3A, S2B, and S2C). Conversely, bicuculline completely
reversed the memory impairment of D1-CB1-KO mice when in-
jected immediately after training or 1 h later without affecting
WT littermates’ performance (Figures 3A, S2B, and S2C).
These data indicate that excessive GABAergic but not gluta-
matergic ionotropic receptor activity is involved in the phenotype
of D1-CB1-KOmice. A large proportion of GABAergic hippocam-
pal interneurons contain CB1R mRNA, which is expressed at
different levels (high CB1R- and lowCB1R-expressing cells; Mar-
sicano and Lutz, 1999). Conversely, D1R mRNA is expressed at
very low levels in the HPC (http://mouse.brain-map.org/
experiment/show/35; data not shown), which makes it difficult
to accurately quantify its expression above background. There-
fore, to pinpoint which CB1R-positive interneurons in the HPC
contain D1R, we combined fluorescence in situ hybridization
for CB1R mRNA in D1-Cre and D1-CB1-KO mice carrying viral
Cre-dependent expression of mCherry (STAR Methods; Fig-
ure 3B). As described (Marsicano and Lutz, 1999), detectable
levels of CB1R mRNA were present throughout the HPC in pyra-
midal neurons and in GABAergic interneurons (Figure S2D). The
distribution of mCherry-tagged D1-positive neurons in the dorsal
CA1 region of D1-Cre mice was similar to previous findings
(Puighermanal et al., 2017; Gangarossa et al., 2012). Double
staining revealed that virtually no high CB1R-expressing inter-
neurons in the strata oriens, pyramidale, radiatum, or lacunosumFigure 2. Learning-Induced Facilitation of In Vivo Hippocampal LTP Re
(A and B) HFS in the dorsal hippocampal CA3 Schaffer collateral pathway induc
(A) Summary plots of recorded evoked fEPSPs in anesthetized D1-CB1-WT (n =
(B) Bar histograms of normalized fEPSPs from (A), representing 30 and 60 min a
(C) Schematic representation of the experimental setup (STAR Methods).
(D and E) Learning modulates in vivo LTP.
(D) Summary plots of recorded evoked fEPSPs from mice exposed to control (n
(E) Bar histograms of normalized of evoked fEPSPs from (D), representing 30 an
(F and G) Learning-induced modulation of in vivo LTP is impaired in D1-CB1-KO
(F) Summary plots of recorded fEPSPs in anesthetized D1-CB1-WT (n = 10) and
(G) Bar histograms of normalized of evoked fEPSPs from (F), representing 30 an
Traces on the right side of the summary plots represent 150 superimposed evoke
HFS. Data, mean ± SEM. *p < 0.05. See also Table S1.moleculare contain D1Rs (Figures 3C–3F and S2D). Conversely,
D1Rs are present in a small subpopulation of low CB1R-express-
ing interneurons along the different hippocampal layers (Figures
3C and 3F). Importantly, this co-expression was virtually abol-
ished in hippocampi of D1-CB1-KO mice (Figures 3C, 3D, and
3F).
Altogether, these data indicate that CB1R-dependent modula-
tion of a small subpopulation of D1R-positive GABAergic inter-
neurons is required during NOR memory consolidation.
Synaptic Mechanisms Underlying NOR Memory
Consolidation and Associated Hippocampal Plasticity
The data collected so far show that reduction of GABAergic
signaling prevents the deficits in D1-CB1-KO mice of NOR
consolidation. Therefore, we tested whether inhibition of
GABAA receptors could rescue the lack of learning-induced
LTP enhancement observed in D1-CB1-KO mice. Trained mice
received bicuculline or vehicle (VEH) before testing LTP induc-
tion in hippocampal circuits. In vehicle-treated animals, D1-
CB1-KO mice showed no training-induced LTP enhancement
(Figures 4A–4C). Strikingly, although bicuculline did not affect
LTP in WT animals, it rescued the training-induced LTP of D1-
CB1-KO mice (Figures 4A–4C).
Recent data suggest that hippocampal D1R-like receptors
participate in memory formation, but little is known concerning
the cell types involved (Lisman et al., 2011; Yamasaki and Take-
uchi, 2017). Our data indicate that CB1R-dependent control of
GABAergic transmission from a low number of hippocampal in-
terneurons expressing D1R is required to guarantee late consol-
idation of NOR memory. Therefore, it is possible that endocan-
nabinoid actions are secondary to activation of D1Rs in these
cells. To address this issue, we first reasoned that partial inhibi-
tion of D1Rs should ‘‘replace’’ the lack of CB1R-dependent con-
trol of neurotransmission in D1-CB1-KOmice. Thus, we adminis-
tered a sub-effective dose of the D1/5R antagonist SCH-23390
(Figures S3A–S3C) to D1-CB1-KO mice and WT littermates after
NOR acquisition and analyzed the training-induced enhance-
ment of in vivo LTP. This treatment slightly reduced the late
phase of LTP in WT animals (Figures 4A–4C). However, the
antagonist abolished the differences between D1-CB1-KO mice
and WT littermates (Figures 4A–4C), indicating that reducing
D1R activity counteracts the absence of CB1Rs in the mutants.
If LTP is mechanistically linked to NOR consolidation, then
the same treatment should rescue the memory impairment ofquires CB1Rs at D1R-Positive Neurons
es in vivo LTP in the dorsal CA1 stratum radiatum.
8) and D1-CB1-KO (n = 8) mice.
fter HFS.
= 8) and NOR training (n = 11) conditions.
d 60 min after HFS.
mice.
D1-CB1-KO (n = 10) mice.
d 60 min after HFS.
d fEPSPs before HFS (1, gray) and 30 min (2, brown) and 60 min (3, black) after
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Figure 3. Hippocampal CB1R/D1R-Positive Interneurons Modulate Synaptic GABAergic Transmission
(A) NORmemory performance of mutant mice administered vehicle (n D1-CB1-WT = 14, n D1-CB1-KO = 14), MK-801 (0.1 mg/kg, intraperitoneally [i.p.]; n D1-CB1-
WT = 7, n D1-CB1-KO = 7), NBQX (5mg/kg, i.p.; n D1-CB1-WT = 8, n D1-CB1-KO = 5), or bicuculline immediately after (n D1-CB1-WT = 10, n D1-CB1-KO = 10) or 1 h
after the training phase (n D1-CB1-WT = 10, n D1-CB1-KO = 8).
(B) Schematic representation of the experimental procedure to detect CB1R mRNA in D1R-positive cells.
(C and D) Representative images of CB1RmRNA (green) andmCherry protein (red) labeling in the hippocampal CA1 region of D1-Cre (C) and D1-CB1-KO (D) mice.
White arrows indicate colocalization of CB1R-positive and D1R-positive cell bodies. Scale bar, 150 mm.
(E and F) Layer-specific distribution of the percentage of cell bodies expressing high (E) and low amounts (F) of CB1Rs, which colocalize with mCherry-positive
(i.e., D1R-positive) in D1-Cre (n = 3) and D1-CB1-KO (n = 3).
Data, mean ± SEM. *p < 0.05, **p < 0.01. See also Figure S2 and Table S1.
Report
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OPEN ACCESSD1-CB1-KO mice. Administration of SCH-23390 did not alter the
behavior ofWTmice (Figures 4D, S3D, and S3E), but, strikingly, it
fully rescued the memory impairment of D1-CB1-KO littermates
(Figures 4D, S3D, and S3E).
Altogether, these results indicate that endocannabinoid-
dependent regulation of hippocampal D1R-positive interneurons
is a necessary step in dopaminergic control of NOR memory
consolidation and associated synaptic plasticity.6 Cell Reports 32, 108046, August 18, 2020DISCUSSION
The present study reveals that a specific subpopulation of hippo-
campal D1R/CB1R-positive neurons controls late consolidation
of NOR memory and associated synaptic plasticity by moder-
ating local inhibitory GABAergic activity in the HPC. Specifically,
CB1Rs expressed in D1R-positive interneurons participate in
learning-induced facilitation of in vivo LTP and are required for
Figure 4. Cellular Mechanisms Linking D1R Signaling with GABAergic Activity during Learning-Induced Facilitation of In Vivo LTP and
Memory Consolidation
(A) Effects of the GABAA receptor antagonist bicuculline and the D1/5R antagonist SCH-23390 on learning-induced modulation of in vivo LTP in D1-CB1-WT and
D1-CB1-KO mice. Shown are summary plots of recorded evoked fEPSPs in vehicle (n D1-CB1-WT = 6, n D1-CB1-KO = 8), bicuculline (0.5 mg/kg, i.p.; n D1-CB1-
WT = 9, n D1-CB1-KO = 11), and SCH-23390 (0.3 mg/kg, i.p.; n D1-CB1-WT = 6, n D1-CB1-KO = 6).
(B and C) Bar histograms of (A), representing normalized fEPSPs from 30 (B) and 60 (C) min after HFS.
(D) Memory performance D1-CB1-WT and D1-CB1-KOmice after being injected with vehicle (n D1-CB1-WT = 6, n D1-CB1-KO = 10) or SCH-23390 (0.3 mg/kg, i.p.;
n D1-CB1-WT = 10, n D1-CB1-KO = 10).
Traces on the right side of the summary plot (A) represent 150 superimposed evoked fEPSPs before HFS (1, gray) and 30min (2, brown) and 60min (3, black) after
HFS. Data, mean ± SEM. *p < 0.05, **p < 0.01.
See also Figure S3 and Table S1.






OPEN ACCESSconsolidation of NORmemory.Moreover, CB1Rs in D1R-positive
neurons are necessary for physiological D1R-dependent modu-
lation of memory processes, suggesting that cannabinoid
signaling is part of a complex modulatory circuit regulated by
dopamine transmission in the HPC. By determining cellular
and behavioral functions of a specific CB1R-expressing inter-
neuron subpopulation, these data uncover an unforeseen role
of CB1Rs in the D1R-dependent control of long-term memory.
The endocannabinoid system regulates episodic-like recog-
nition memory processes via CB1R-dependent control of
different cell types in the HPC (Busquets-Garcia et al., 2017;
Soria-Gomez et al., 2017; Busquets Garcia et al., 2016; Puigh-
ermanal et al., 2009; Robin et al., 2018). In the present study,
we observed that the transition from short- to long-term mem-
ory processes is controlled by a functional interaction between
D1Rs and CB1Rs in a specific subpopulation of hippocampal
interneurons. In contrast, CB1R deletion from all body cells or
in all forebrain GABAergic neurons does not reproduce the
phenotype of D1-CB1-KO mice (Puighermanal et al., 2009;
Hebert-Chatelain et al., 2016). These apparently contrasting
observations can be explained by different possibilities. Long-
term deletion of the CB1R gene starting from early develop-
mental stages in CB1-KO and GABA-CB1-KO mice might
induce compensatory mechanisms (El-Brolosy et al., 2019;
El-Brolosy and Stainier, 2017), masking the functional role of
the CB1R in NOR memory. An alternative or complementary
explanation might point to the presence of different subpopula-
tions of brain cells expressing CB1Rs and exerting opposite ef-
fects on memory processes. For instance, endocannabinoid
signaling might promote or inhibit memory formation when
acting at D1R-positive cells or at other neuronal subpopula-
tions, respectively. We have shown previously that astroglial
CB1Rs are necessary for consolidation of NOR memory by al-
lowing D-serine availability at glutamatergic synapses (Robin
et al., 2018). We cannot fully exclude that deletion of CB1Rs
in D1R-positive cells does not also involve astrocytes (Naga-
tomo et al., 2017). However, so far, no conclusive anatomical
evidence has been presented for expression of D1Rs in hippo-
campal astrocytes (Chai et al., 2017; Zhang et al., 2014; but see
Jennings et al., 2017 for D1/5R pharmacological experiments).
Moreover, our current and past results suggest that endocan-
nabinoid control of astrocytes is likely involved in the initial
phases of memory formation, whereas CB1R-dependent inhibi-
tion of D1R-positive hippocampal interneurons determines later
phases of NOR memory consolidation. The time-course effects
of pharmacological treatments indicate that D-serine can
rescue memory performance of GFAP-CB1-KO mice only
when administered immediately after learning (Robin et al.,
2018). This idea is reinforced by the fact that these mutants
do not express in vivo LTP even under basal ‘‘home cage’’ con-
ditions (Robin et al., 2018), whereas D1-CB1-KO mice only lack
the specific facilitation of LTP induced by learning. Altogether,
these observations allow speculation that at least two distinct
temporal windows exist in CB1R-dependent control of NOR.
First, astroglial CB1R are necessary for the plastic processes
to initiate the memory. Later, endocannabinoid-dependent
regulation of D1R-positive interneurons is required to maintain
the memory trace for longer periods.8 Cell Reports 32, 108046, August 18, 2020Hippocampal D1R have been shown previously to be mainly
on GABAergic interneurons, but lower levels were also detected
on glutamatergic neurons (Gangarossa et al., 2012; Puigherma-
nal et al., 2017; http://celltypes.brain-map.org/rnaseq/
mouse_ctx-hip_smart-seq). Our data show that the D1-Cre
mouse line used in the present study (Lemberger et al., 2007) in-
duces recombination in a small sub-fraction of hippocampal in-
terneurons containing low levels of CB1RmRNA but also in pyra-
midal neurons and mossy cells. Therefore, we cannot fully
exclude that cell types other than hippocampal interneurons
might participate in D1R/CB1R-dependent control of memory
consolidation. However, our data show that partial blockade of
GABAA receptors, but not of AMPA/kainate or NMDA glutama-
tergic ones, reverse the memory impairment of D1-CB1-KO
mice. Therefore, our findings strongly suggest that CB1R control
of GABA release from D1R-positive interneurons regulates late
consolidation of NOR memory. However, recent data using
emerging technologies suggest that hippocampal cells are
more diverse and functionally segregated than previously
thought (Harris et al., 2018; Soltesz and Losonczy, 2018). By
identifying specific markers, future studies will extend our ge-
netic and pharmacological evidence that a specific subpopula-
tion of D1R/CB1R-positive hippocampal interneurons regulates
consolidation of NOR memory.
LTP at the CA3-CA1 pathway is a potential molecular and
cellular mechanism underlying behavioral expression of
episodic-like memory processes (Morris, 2013). Interestingly,
although deletion of CB1Rs from D1R-positive cells impairs
NOR memory, the same manipulation does not impair in vivo
LTP of hippocampal synaptic transmission in naive animals. In
agreement with previous evidence under other experimental
conditions (Li et al., 2003; Lemon and Manahan-Vaughan,
2006), WT mice exposed to the NOR learning task display facil-
itation of in vivo LTP compared with animals exposed to the
same environment without any learning. Importantly, this facilita-
tion is absent in D1-CB1-KOmice, suggesting that endocannabi-
noid control of D1R-positive hippocampal interneurons is re-
cruited only after learning. The facilitation might be due to
‘‘real’’ stronger synaptic transmission after learning or a
decrease in baseline synaptic activity (Lisman, 2017), which
might be occluded in D1-CB1-KO mice. The fact that partial
blockade of GABAA receptors in trained WT mice does not alter
LTP facilitation suggests that this phenomenon is due to a
genuine increase in LTP. In addition, our data indicate that
reducing GABAergic transmission in D1R-positive neurons is
required for this form of learning-induced synaptic plasticity.
These results reinforce the idea that, to reveal relevant mecha-
nisms, investigations of synaptic plasticity associatedwithmem-
ory processes should include not only naive animals but also
behaviorally challenged ones (Lisman et al., 2011).
D1R activity in the HPC is necessary for long-term memory,
synaptic plasticity, and network dynamics (Lisman et al., 2011;
Yamasaki and Takeuchi, 2017; Kaufman et al., 2020; Bethus
et al., 2010). Consistently, our results show that high doses of
the D1/5R antagonist SCH-23390 impair memory performance in
the NOR task. In addition, our data suggest that D1R/CB1R-pos-
itive hippocampal interneurons are one of the targets of dopami-
nergic control of learning and memory processes. Interestingly, it
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require D1R activity for late phases of memory consolidation
through coordinated control of the activity of hippocampal pyra-
midal neurons (Karunakaran et al., 2016). Particularly, the authors
describe that this D1R activity modulates hippocampal network
oscillations (i.e., sharp-wave ripples), which is a proposed corre-
late for synaptic plasticity and memory consolidation (Buzsáki,
2015). In addition, previous studies have shown that PV/CB1R-
negative and CCK/CB1R-positive interneurons have complemen-
tary roles in ensuring such high oscillatory ripple events with
consequent capacity tomodulate synaptic plasticity (Klausberger
et al., 2005; Buzsáki, 2015). Therefore, we speculate that the sub-
population of D1R/CB1R-positive interneurons described in our
work could play a complementary role in maintaining a proper
excitation/inhibition balance in the hippocampal network activity
required for memory consolidation.
Although complete elucidation of the complex microcircuitry
requires further characterization, our findings support the hy-
pothesis that D1R/CB1R-positive hippocampal interneurons
belong to a broader circuit participating in dopaminergic control
of memory (Yamasaki and Takeuchi, 2017). Our data are
compatible with a scenario where D1R activation during the
learning/consolidation process potentiates GABAergic trans-
mission. However, this D1R-dependent increase in inhibition is
kept within adequate limits by activation of CB1Rs, allowing
proper flow of information. In this sense, in the absence of
CB1R-dependent control of D1R/CB1R-positive interneurons
(i.e., D1-CB1-KO mice), partial inhibition of D1-like or GABAA re-
ceptors rescues the phenotype. In other words, although activa-
tion of D1Rs in interneurons seems to be necessary for the mem-
ory process, their abnormally high activity (e.g. in the absence of
CB1Rs) impairs such functions. In this context, an interesting
question relates to the functional link between endogenous acti-
vation of D1Rs and CB1Rs. Our results allow speculation about
two potential scenarios based on autocrine or paracrine modes
of action of endocannabinoid signaling (Busquets-Garcia et al.,
2017). (1) General D1R-dependent dopaminergic signaling in
the HPC might activate pyramidal neurons (Roggenhofer et al.,
2013; Shivarama Shetty et al., 2016) targeted by D1R/CB1R-pos-
itive interneurons. This depolarization of pyramidal neurons
would, in turn, induce canonical endocannabinoid-dependent
retrograde inhibition of GABAergic release (Castillo et al.,
2012), moderating, among others, activation of D1R/CB1R-pos-
itive interneurons. (2) Following D1R activation and consequent
interneuron depolarization (Anastasiades et al., 2019; Gorelova
et al., 2002), endocannabinoids might be mobilized locally and
act in an autocrine manner to decrease the membrane potential
and thereby moderate the activity of the neuron (Bacci et al.,
2004). These two possibilities are not mutually exclusive, and
they might reflect the effect of the mechanisms described on
general network activity and/or on specific plastic cellular pro-
cesses, respectively. Future studies will investigate these
intriguing scenarios using adapted experimental approaches.
Altogether, these data reveal that functionally distinct cell types
are present in the general population of hippocampal GABAergic
interneurons expressing CB1Rs. In particular, D1R/CB1R-positive
interneurons provide specific behavioral and hippocampal synap-
tic mechanisms sustaining the fine-tuned regulation of memoryprocesses. The close interaction of CB1Rs and D1Rs in modu-
lating recognitionmemorymight provide novel therapeutic frame-
works for treatment of cognitive diseases characterized by alter-
ations of endocannabinoid or dopaminergic systems or both.
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Granado, N., Ortiz, O., Suárez, L.M., Martı́n, E.D., Ceña, V., Solı́s, J.M., and
Moratalla, R. (2008). D1 but not D5 dopamine receptors are critical for LTP,
spatial learning, and LTP-Induced arc and zif268 expression in the hippocam-
pus. Cereb. Cortex 18, 1–12.
Harris, K.D., Hochgerner, H., Skene, N.G., Magno, L., Katona, L., Bengtsson
Gonzales, C., Somogyi, P., Kessaris, N., Linnarsson, S., and Hjerling-Leffler,
J. (2018). Classes and continua of hippocampal CA1 inhibitory neurons re-
vealed by single-cell transcriptomics. PLoS Biol. 16, e2006387.
Hebert-Chatelain, E., Desprez, T., Serrat, R., Bellocchio, L., Soria-Gomez, E.,
Busquets-Garcia, A., Pagano Zottola, A.C., Delamarre, A., Cannich, A., Vin-
cent, P., et al. (2016). A cannabinoid link between mitochondria and memory.
Nature 539, 555–559.
Jennings, A., Tyurikova, O., Bard, L., Zheng, K., Semyanov, A., Henneberger,
C., and Rusakov, D.A. (2017). Dopamine elevates and lowers astroglial Ca2+
through distinct pathways depending on local synaptic circuitry. Glia 65,
447–459.
Karunakaran, S., Chowdhury, A., Donato, F., Quairiaux, C., Michel, C.M., and
Caroni, P. (2016). PV plasticity sustained through D1/5 dopamine signaling
required for long-term memory consolidation. Nat. Neurosci. 19, 454–464.
Katona, I., and Freund, T.F. (2012). Multiple functions of endocannabinoid
signaling in the brain. Annu. Rev. Neurosci. 35, 529–558.
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Rabbit antibody against the C-myc epitope tag BioLegend Cat# 906301; RRID:AB_2565064
Goat anti-rabbit antibody Alexa Fluor 488 Fisher Scientific Cat# A-11008; RRID:AB_143165
4’,6-diamidino-2-phenylindole Fisher Scientific Cat# D3571; RRID:AB_2307445
Rabbit polyclonal antibody against DsRed Takara Bio Cat# 632496; RRID:AB_10013483
Secondary antibody goat anti-rabbit conjugated to a horseradish
peroxidase
Cell signaling Cat#7074S; RRID:AB_2099233
Digoxigenin (DIG)-labeled riboprobe against mouse CB1 Marsicano and Lutz, 1999 N/A
Anti-DIG antibody conjugated to HRP Roche Cat#11207733910; RRID:AB_514500
Bacterial and Virus Strains
rAAV-CAG-DIO Lead contact lab rAAV-30
AAV-CAG-DIO-CB1 Lead contact lab rAAV-37
AAV-CAG-DIO-CB1-myc Lead contact lab rAAV-21
hSyn-DIO-hM4D(Gi)-mCherry Addgene 44361-AAV8
pAAV-hSyn-DIO-mCherry Addgene 50459-AAV8
Chemicals, Peptides, and Recombinant Proteins
2-methylbutane Sigma-Aldrich M32631-1L
TSA plus fluorescein system Perkin Elmer NEL741001KT
Streptavidin-Texas Red Perkin Elmer NEL721001EA
Normal donkey serum Merck S30-100ML
Sheep Serum Sigma Aldrich S3772-10ML
Formaldehyde 4% Sigma Aldrich HT501128-4L
Blocking reagent (to prepare NEN) Perkin Elmer FP1012
TSA Biotin Systems Perkin Elmer NEL700A001KT
SSC 20X Sigma 93017-10L-F
Fluoromount-GSlide Mounting Medium Electron microscopy sciences 17984-25
Isoflurane Virbac Vnr137317
Bicuculine Sigma-Aldrich 14343-50MG
SCH 23390 Sigma-Aldrich D054-10MG
MK-801 Sigma-Aldrich 77086-22-7
clozapine-N-oxide CNO Tocris 4936
Critical Commercial Assays
Avidin/Biotin Blocking Kit Vector Labs SP-2001
Experimental Models: Organisms/Strains
D1-CB1-WT and D1-CB1-KO Lead contact lab N/A
C57BL/6N Janvier Labs C57BL/6NRj
D1-Cre Lead contact lab Tg(Drd1a-cre)AGsc/KndlJ,
CB1
flox/flox Lead contact lab Cnr1tm1.2Ltz, MGI:3045419
GFAP-CB1-WT and GFAP-CB1-KO Lead contact lab N/A
Software and Algorithms
Prism Graphpad Software V6.0
CED 1401 Spike2 Cambridge Electronic Design V6.18





Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Giovanni
Marsicano (giovanni.marsicano@inserm.fr).
Materials Availability
Mouse lines generated and used in the current study are available from the lead contact upon request. We are glad to share the
mouse lines with reasonable compensation by requestor for its processing and shipping.
Data and Code Availability
The data supporting the current study have not been deposited in a public repository but are available from the lead contact on
request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal Model
All experimental procedures were approved by the ethical committee of the FrenchMinistry of Higher Education, Research and Inno-
vation (authorization APAFIS#18111). Maximal efforts were made to reduce the suffering of the animals. Male mice were used in this
study.
D1-CB1-KO mice were generated as previously described (Monory et al., 2007; Terzian et al., 2011). Briefly, CB1 floxed mice
(Marsicano et al., 2003) were crossed with D1-Cre line (Lemberger et al., 2007), in which the Cre recombinase was placed under
the control of the D1 gene (Drd1a) regulatory sequences using transgenesis with modified bacterial artificial chromosomes. The
pattern of Cre expression recapitulated the expression pattern of the endogenous Drd1a (Lemberger et al., 2007). Breeding was per-
formed by mating male Cre-positive D1-CB1-KO mice with homozygous CB1-flox female mice deriving from a separate colony. In
order to detect possible germline or ectopic recombination events, genotyping of tail samples from pups (PD10) was performed
by genomic PCR using primers suited to identify WT, ‘‘floxed’’ and ‘‘recombined’’ bands. No germline or ectopic recombination
was detected. Eight to 14 weeks-old naive male D1-CB1-KO and WT littermates were used. 8-14 weeks old male C57BL/6NRj
mice purchased from Janvier (France). 8-12 weeks-old D1-Cre mice breed in the animal facilities of the U1215 we also used. Animals
were housed collectively under standard conditions of temperature and humidity in a day/night cycle of 12/12 hours (light on at 7 am).
Animals that underwent surgery were kept in individual cages after the procedures to avoid conflict with their littermates. Food and
water were provided ad libitum. All the experiments were performed during the light phase. Behavioral experiments were performed
from 9 am to 3 pm. Electrophysiology experiments were performed from 8 am to 7 pm.
METHOD DETAILS
Drug preparation and administration
Bicuculline, MK-801, NBQX and SCH-23390 were purchased from Merck (formerly Sigma-Aldrich, France) and were dissolved to
their final concentration in physiological saline (NaCl 0.9%). The exogenous DREADD ligand clozapine-N-oxide (CNO, 2 mg/kg)
was purchased from Tocris Bioscience (Bristol, UK) and dissolved in saline after gently mixing with a vortex. All drugs were injected
intraperitoneally in a volume of 10 ml/kg. Vehicle in all the conditions was composed of physiological saline (NaCl 0.9%) injections.
Novel object recognition memory
We used the novel object recognition (NOR) memory task in an L-maze (Busquets-Garcia et al., 2011, 2013; Hebert-Chatelain et al.,
2016; Puighermanal et al., 2009, 2013; Robin et al., 2018).
The task took place in a L-shapedmazemade of dark gray polyvinyl chloridemade by two identical perpendicular arms (35 cm and
30 cm long respectively for external and internal L walls, 4.5cmwide and 15 cm high walls) placed on a white background (Busquets-
Garcia et al., 2011; Puighermanal et al., 2009). The task occurred in a room adjacent to the animal house with a light intensity fixed at
50 lux. Themaze was overhung by a video camera allowing the detection and offline scoring of animal’s behavior. The task consisted
in 3 sequential daily trials of 9 minutes each. During the habituation phase (day 1), mice were placed in the center of the maze and
allowed to freely explore the arms in the absence of any objects. The training phase (day 2) consisted in placing the mice again in the
corner of themaze in the presence of two identical objects positioned at the extremities of each arm and left to freely explore themaze
and the objects. The testing phase occurred 24 hours later (day 3): one of the familiar objects was replaced by a novel object different
in its shape, color and texture and mice were left to explore both objects. The position of the novel object and the associations of
novel and familiar were randomized. All objects were previously tested to avoid biased preference. Memory performance was as-
sessed by the discrimination index (DI). The DI was calculated as the difference between the time spent exploring the novel (TN)
and the familiar object (TF) divided by the total exploration time (TN+TF): DI = [TN-TF]/[TN+TF]. Memory was also evaluated by
directly comparing the exploration time of novel and familiar objects, respectively. Object exploration was defined as the orientationCell Reports 32, 108046, August 18, 2020 e2
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OPEN ACCESSof the nose to the object at less than 2 cm. Experienced investigators evaluating the exploration were blind of treatment and/or ge-
notype of the animals. Pharmacological treatments were immediately administered after the training phase.
In vivo electrophysiology in anesthetized mice
Experiments were performed as described in Robin et al. (2018). Mice were anesthetized in a box containing 5% Isoflurane (Virbac,
France) before being placed in a stereotaxic frame (Model 900, Kopf instruments, CA, USA) in which 1.0% to 1.5% of Isoflurane was
continuously supplied via an anesthetic mask during the whole duration of the experiment. The body temperature was maintained at
± 36.5C using a homeothermic system (model 50-7087-F, Harvard Apparatus, MA, USA) and the state of anesthesia was assessed
by mild tail pinch. Before surgery, 100 mL of the local anesthetic lurocaine (vetoquinol, France) was injected in the scalp region. Sur-
gical procedure started with a longitudinal incision of 1.5 cm in length aimed to expose Bregma and Lambda. After ensuring the cor-
rect alignment of the head, two holes were drilled in the skull for electrode placement. Glass recording electrodes were inserted in the
CA1 stratum radiatum, and a concentric stimulating bipolar electrode (Model CBARC50, FHC, ME, USA) placed in the CA3 region.
Coordinates were as follows: CA1 stratum radiatum: A/P 1.5,M/L 1.0, DV 1.20; CA3: A/P 2.2,M/L 2.8, D/V 1.3 (20 insertion angle). The
recording electrode (tip diameter = 1–2mm, 2-4MU) was filled with a 2%pontamine sky blue solution in 0.5M sodium acetate. At first
the recording electrodewas placed by hand until it reached the surface of the brain and then to the final depth using a hydraulicmicro-
positioner (Model 2650, KOPF instruments, CA, USA). The stimulation electrode was placed in the correct area using a standard
manipulator. Both electrodes were adjusted to find the area with maximum response. In vivo recordings of evoked field excitatory
postsynaptic potentials (fEPSPs) were amplified 1000 times and filtered (low-pass at 1Hz and high-pass 3000Hz) by a DAGAN
2400A amplifier (DAGAN Corporation, MN, USA). fEPSPs were digitized and collected on-line using a laboratory interface and soft-
ware (CED 1401, SPIKE 2; Cambridge Electronic Design, Cambridge, UK). Test pulses were generated through an Isolated Constant
Current Stimulator (DS3, Digitimer, Hertfordshire, UK) triggered by the SPIKE 2 output sequencer via CED 1401 and collected every
2 s at a 10 kHz sampling frequency and then averaged every 180 s. Test pulse intensities were typically between 40-250 mA with a
duration of 50 ms. Basal stimulation intensity was adjusted to 30%–50% of the current intensity that evoked a maximum field
response. All responses were expressed as percent from the average responses recorded during the 15 min before high frequency
stimulation (HFS). HFSwas induced by applying 3 trains of 100Hz (1 s each), separated by 20 s interval. fEPSPwere then recorded for
a period of 60 min. C57BL6/NRj mice underwent this in vivo electrophysiology procedure after the training phase of NOR task.
Also, where specified, D1-CB1-KO and D1-CB1-WT received an injection of Bicuculine (0.5 mg/kg, intraperitoneal) or SCH 23390
(0.3 mg/kg, intraperitoneal) or vehicle immediately after undergoing training in NORT and before being subjected to the in vivo
electrophysiology procedure. At the end the experiment, the position of the electrodes was marked (recording area: iontophoretic
infusion of the recording solution during 180 s at 20mA; stimulation area: continuous current discharge over 20 s at +20mA) and
histological verification was performed ex vivo.
Surgery and viral administration
Mice were anesthetized in a box containing 5% Isoflurane (Virbac, France) before being placed in a stereotaxic frame (Model 900,
Kopf instruments, CA, USA) in which 1.0% to 1.5% of Isoflurane was continuously supplied via an anesthetic mask during the whole
duration of the experiment. For viral intra-HPC AAV delivery, mice were submitted to stereotaxic surgery (as above) and AAV
vectors were injected with the help of a microsyringe (0.25 mL Hamilton syringe with a 30-gauge beveled needle) attached to a
pump (UMP3-1, World Precision Instruments, FL, USA). Where specified, D1-CB1-WT and D1-CB1-KO mice were injected directly
into the hippocampus (HPC) or striatum (STR) (0.5 ml per injection site at a rate of 0.5 ml per min), with the following coordinates:
HPC, AP 1.8; ML ± 1; DV 2.0 and 1.5; Striatum: AP 1.34; ML ± 2.8; DV 1.84. Following virus delivery, the syringe was left
in place for 1minute before being slowly withdrawn from the brain. CB1 floxedmice were injected with rAAV-CAG-DIO (empty control
vector), AAV-CAG-DIO-CB1 or AAV-CAG-DIO-CB1-myc to induce re-expression of the CB1 receptor gene in hippocampal or striatal
D1-positive cells. To generate the aforementioned rAAVs, mouseCB1 receptor coding sequence (either native or fused to myc-tag at
the C term) was cloned in rAAV-CAG-DIO vector using standard molecular cloning technology. The coding sequence was cloned
inverted in orientation to allow Cre-dependent expression of CB1 receptors (Atasoy et al., 2008). In another experiment, and
using the same procedure as described as above, D1-CB1-WT and D1-CB1-KO mice were injected intra hippocampally (AP 1.8;
ML ± 1; DV 2.0 and 1.5), with pAAV-hSyn-DIO-hM4D(Gi)-mCherry or pAAV-hSyn-DIO-mCherry (addgene, USA). For anatomical
experiments and using the same procedure as above, D1-Cre and D1-CB1-KO were injected intra hippocampally with pAAV-hSyn-
DIO-mCherry. In this specific experiment, expression was allowed to take place for 2 weeks. For the remaining experiments, animals
were used around 4-5 weeks after local infusions. Mice were weighed daily and individuals that failed to regain the pre-surgery body
weight were excluded from the following experiments.
Immunohistochemistry on free-floating sections
Mice were anesthetized with pentobarbital (Exagon, Axience SAS, 400 mg/kg body weight), transcardially perfused with phosphate-
buffered solution (PBS 0.1M, pH 7.4) before being fixed with 4% formaldehyde (Sigma-Aldrich). The The brains were extracted and
incubated overnight at 4C in the same fixative, then embedded with sucrose 30% for 3 days and finally frozen in 2-methylbutane
(Sigma-Aldrich) at 80C. Free-floating frozen coronal sections (40 mm) were cut out with a cryostat (Microm HM 500M Microm
Microtech), collected collected in an antifreeze solution and conserved at20C. Sections were permeabilized in a blocking solutione3 Cell Reports 32, 108046, August 18, 2020
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OPEN ACCESS(in PBS: 10% donkey serum, 0.3% Triton X-100) for 1 hour at room temperature (RT). Then, sections were incubated with a rabbit
primary antibody against the C-myc epitope tag (1:1000, BioLegend) overnight at 4C. After several washes with PBS, slices
were incubated for 2 hours with a secondary antibody goat anti-rabbit Alexa Fluor 488 (1:500, Fisher Scientific) and then washed
in PBS at RT. Finally, sections were incubated with 4’,6-diamidino-2-phenylindole (DAPI 1:20000, Fisher Scientific) diluted in PBS
for 5 minutes to visualize cell nuclei and then were washed, mounted and coverslipped. All the antibodies were diluted in blocking
solution. The sections were imagedimaged with a slides scanner Hamamatsu Nanozoomer 2.0 HT.
Combined Fluorescent in situ hybridization (FISH)/ Immunohistochemistry (IHC) on free-floating frozen sections
Mice were anesthetized with pentobarbital (Exagon, Axience SAS, 400 mg/kg body weight), transcardially perfused with PBS (0.1M,
pH 7.4) before being fixed with 4% formaldehyde (Sigma-Aldrich). The brains were extracted and incubated overnight at 4C in the
same fixative, then embedded with sucrose 30% for 3 days and finally frozen in 2-methylbutane (Sigma-Aldrich) at 80C. Free-
floating frozen coronal sections were cut out with a cryostat (30 mm, Microm HM 500M Microm Microtech) and collected in an anti-
freeze solution and conserved at 20C.
Section were washed several times with PBS with diethyl pyrocarbonate (PBS-DEPC) to wash out the antifreeze solution. The
endogenous peroxidases were inactivated by incubating the free-floating sections with 3% H2O2 in PBS-DEPC for 30 minutes. All
endogenous biotin, biotin receptors, and avidin binding sites present in the tissue were blocked by using the Avidin/Biotin Blocking
Kit (Vector Labs, USA). Then, the slices were incubated overnight at RT with a rabbit polyclonal primary antibody against DsRed
(1:1000, Takara Bio) diluted in a blocking solution (0.3% Triton X-100 diluted in PBS-DEPC). The following day, after several washes,
the sections were incubated with a secondary antibody goat anti-rabbit conjugated to a horseradish peroxidase (HRP) (1:500, Cell
Signaling Technology) during 2 hours at RT followed by TSA Biotin System (Biotin TSA 1:100, PerkinElmer) for 10 minutes at RT.
After several washes, the slices were fixed with 4% of formaldehyde (Sigma Aldrich) for 10 minutes and blocked with 0.2M HCl
for 20 minutes at RT. Then, the section were acetylated in 0.1 M Triethanolamine, 0.25% Acetic Anhydride for 10 minutes.
This step was performed to reduce non-specific probe binding. Sections were hybridized overnight at 60C with Digoxigenin
(DIG)-labeled riboprobe against mouse CB1 receptor (1:1000, prepared as described in Marsicano and Lutz, 1999). After hybridiza-
tion, the slices were washed with different stringency wash buffers at 65C. Then, the sections were incubated with 3% of H2O2 for
30minutes at RT and blocked 1 hour with NENblocking buffer prepared according to themanufacturer’s protocol (PerkinElmer). Anti-
DIG antibody conjugated to HRP (1:2000, Roche) was applied for 2 hours at RT. The signal of CB1 receptor hybridization was revealed
by a TSA reaction using fluorescein isothiocyanate (FITC)-labeled tyramide (1:80 for 12 minutes, Perkin Elmer). After several washes,
the free-floating slices were incubated overnight at 4C with Streptavidin-Texas Red (1:400, PerkinElmer). Finally, the slices were
incubated with DAPI (1:20000; Fisher Scientific) diluted in PBS, following by several washes, to finally be mounted, coverslipped
and imaged with an epifluorescence Leica DM 6000 microscope (Leica, Germany).
QUANTIFICATION AND STATISTICAL ANALYSIS
Data collection
No statistical methods were used to pre-determine sample sizes, but they are similar to those reported in previous publications. All
data collection and/or analysis were performed blind to the conditions of the experimenter except for the in vivo electrophysiological
experiments. All mice were assigned randomly to the different experimental conditions.
Fluorescence quantifications
Cells expressing mRNAs were quantified in the different layers (stratum oriens, stratum pyramidale, stratum radiatum and stratum
lacunosum moleculare) of the dorsal hippocampus. CB1 receptor positive cells were classified according to the level of transcript
visualized by the intensity of fluorescence (Marsicano and Lutz, 1999; Terral et al., 2019). ‘‘High-CB1’’ cells were considered to be
round-shaped and intense staining covering the entire nucleus whereas ‘‘Low-CB1’’ cells were defined with discontinuous shape
and lowest intensity of fluorescence allowing the discrimination of grains of staining.
Statistical analyses
Data were expressed as mean ± SEM or single data points and were analyzed with Prism 6.0 (Graphpad Software), using two-tails t
test (paired, unpaired) or one-way ANOVA (Dunnett’s), two-way ANOVA (sidak’s). Sample sizes and p values can be found in figure
legends and Table S1.Cell Reports 32, 108046, August 18, 2020 e4
